Abstract:Continued, rapid development of antimicrobial resistance has become worldwide health crisis and a burden on the global economy. Decisive and comprehensive action is required to slow down the spread of antibiotic resistance, including increased investment in antibiotic discovery, sustainable policies that provide returns on investment for newly launched antibiotics, and public education to reduce the overusage of antibiotics, especially in livestock and agriculture. Without significant changes in the current antibiotic pipeline, we are in danger of entering a post-antibiotic era.In this Account, we summarize our recent efforts to develop next-generation streptogramin and lankacidin antibiotics that overcome bacterial resistance by means of modular chemical synthesis. First, we describe our highly modular, scalable route to four natural group A streptogramins antibiotics in 6–8 steps from seven simple chemical building blocks. We next describe the application of this route to the synthesis of a novel library of streptogramin antibiotics informed by in vitro and in vivo biological evaluation and high-resolution cryo-electron microscopy. One lead compound showed excellent inhibitory activity in vitro and in vivo against a longstanding streptogramin-resistance mechanism, virginiamycin acetyltransferase. Our results demonstrate that the combination of rational design and modular chemical synthesis can revitalize classes of antibiotics that are limited by naturally arising resistance mechanisms.Second, we recount our modular approaches toward lankacidin antibiotics. Lankacidins are a group of polyketide natural products with activity against several strains of Gram-positive bacteria but have not been deployed as therapeutics due to their chemical instability. We describe a route to several diastereomers of 2,18-seco-lankacidinol B in a linear sequence of ≤8 steps from simple building blocks, resulting in a revision of the C4 stereochemistry. We next detail our modular synthesis of several diastereoisomers of iso-lankacidinol that resulted in the structural reassignment of this natural product. These structural revisions raise interesting questions about the biosynthetic origin of lankacidins, all of which possessed uniform stereochemistry prior to these findings. Finally, we summarize the ability of several iso- and seco-lankacidins to inhibit the growth of bacteria and to inhibit translation in vitro, providing important insights into structure–function relationships for the class.This article has not yet been cited by other publications.

Lincosamide Antibiotics; Structure, Activity, and Biosynthesis

Studies of lincosamide formation complete the biosynthetic pathway for lincomycin A

Molecular basis for the diversification of lincosamide biosynthesis by pyridoxal phosphate-dependent enzymes

Structure-Function Analysis of the S-Glycosylation Reaction in the Biosynthesis of Lincosamide Antibiotics

Chemical Synthesis and Biological Activity of Analogues of the Lantibiotic Epilancin 15X

Characterization of compound A, a novel lincomycin derivative active against methicillin-resistant Staphylococcus aureus

A synthetic antibiotic overcomes antimicrobial resistance

Recent development and fighting strategies for lincosamide antibiotic resistance

Establishing the Comprehensive Structure−Activity Relationship of the Natural Antibiotic Kibdelomycin/Amycolamicin

Discovery of actinomycin L, a new member of the actinomycin family of antibiotics

Biosynthesis of C-nucleoside antibiotics in actinobacteria: recent advances and future developments

Structure-Activity Relationship Studies of the Peptide Antibiotic Clovibactin

Modular Chemical Synthesis of Streptogramin and Lankacidin Antibiotics

Olikomycin A – A Novel Calcium‐Dependent Lipopeptide With Antibiotic Activity Against Multidrug‐Resistant Bacteria

Structure, biosynthesis and activity of indolactam alkaloids

Structure-Activity Relationships and Mechanism of Action of Macrolides Derived from Erythromycin as Antibacterial Agents

Synthesis and Evaluation of 8,4 '-Dideshydroxy-leinamycin Revealing New Insights into the Structure-Activity Relationship of the Anticancer Natural Product Leinamycin

Progress on synthesis and structure-activity relationships of lamellarins over the past decade

The Calcium-Dependent Antibiotics: Structure-Activity Relationships and Determination of their Lipid Target

Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibiotics

The antibacterial activity and structure-activity relationship of lactivicin derivatives